Eric Lefebvre's Net Worth
$7.67 Million
Who is Eric Lefebvre?
Eric Lefebvre has an estimated net worth of $7.67 Million. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., PLIANT THERAPEUTICS, INC., and Regado Biosciences Inc.
SEC CIK
Eric Lefebvre's CIK is 0001614741
Past Insider Trading and Trends
2023 was Eric Lefebvre's most active year for acquiring shares with 5 total transactions. Eric Lefebvre's most active month to acquire stocks was the month of December. 2021 was Eric Lefebvre's most active year for disposing of shares, totalling 5 transactions. Eric Lefebvre's most active month to dispose stocks was the month of February. 2022 saw Eric Lefebvre paying a total of $0.00 for 276,876 shares, this is the most they've acquired in one year. In 2023 Eric Lefebvre cashed out on 101,066 shares for a total of $3,027,838.14, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CymaBay Therapeutics, Inc. (CBAY) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PLIANT THERAPEUTICS, INC. (PLRX) Snapshot price: $12.87
Chief Medical OfficerEric Lefebvre owns 213,052 units of Common Stock which is worth $2,741,979.24. From 2020 to 2024 Eric Lefebvre acquired a total of 211,463 shares in PLIANT THERAPEUTICS, INC., Eric also disposed a total of 180,067 shares of PLIANT THERAPEUTICS, INC. equalling to $4,926,088.13.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -5.47% | -12.32K |
$11.56 | -$142,407.64 | 213.05K |
Scheduled
|
Jul 10
| ||
Form 4
| +11.95% | 24.06K |
—
|
—
| 225.37K |
Jul 9
| |||
Form 4
| +27.34% | 42.9K |
—
|
—
| 199.82K |
Jan 23
| |||
Form 4
| -6.16% | -10.29K |
$17.23 | -$177,382.85 | 156.92K |
Scheduled
|
Jan 17
| ||
Form 4
| -11.78% | -22.32K |
$18.01 | -$401,981.12 | 167.22K |
Jul 17
| |||
Form 4
| +30.01% | 43.75K |
—
|
—
| 189.54K |
Jul 14
| |||
Form 4
| -7.16% | -11.24K |
$26.52 | -$298,227.52 | 145.79K |
Mar 30
| |||
Form 4
| +16.18% | 21.87K |
—
|
—
| 157.03K |
Mar 29
| |||
Form 4
| +74.10% | 57K |
—
|
—
| 133.93K |
Jan 25
| |||
Form 4
| -46.74% | -67.50K |
$34.48 | -$2,327,629.50 | 76.93K |
Scheduled
|
Jan 23
| ||
Form 4
| +8.24% | 10.99K |
$19.10 | -$207,967.83 | 144.43K |
Dec 19 - Dec 20
| |||
Form 4
| -3.61% | -5.00K |
$25.05 | -$125,241.00 | 133.44K |
Scheduled
|
Oct 25
| ||
Form 4
| -2.12% | -3.00K |
$20.00 | -$60,000.00 | 138.44K |
Scheduled
|
Jul 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
| -8.36% | -12.50K |
$28.87 | -$360,821.21 | 137.08K |
Scheduled
|
Jun 18
| ||
Form 4
| -7.71% | -12.50K |
$39.41 | -$492,677.75 | 149.58K |
Scheduled
|
Mar 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| -7.16% | -12.50K |
$26.54 | -$331,751.72 | 162.08K |
Scheduled
|
Dec 18
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Regado Biosciences Inc No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||